Cancer Trial Tests Novel Immune Booster BAY 2416964 With Pembrolizumab
Researchers tested a new drug combination targeting immune suppression in advanced solid tumors before early termination.
Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity
318 articles
Researchers tested a new drug combination targeting immune suppression in advanced solid tumors before early termination.
Phase II trial tested nivolumab with or without ipilimumab in 164 patients with metastatic sarcoma that couldn't be surgically removed.
French researchers test intraperitoneal nivolumab after surgery and heated chemotherapy for advanced ovarian cancer patients.
Phase 3 trial compared therapeutic vaccine OSE2101 to chemotherapy in 219 lung cancer patients after immunotherapy failure.
Eight-week study of weekday-only intermittent fasting in older breast cancer survivors with overweight demonstrates feasibility.
French researchers studied how tiny cellular packages called exosomes may help melanoma cells resist treatment and spread throughout the body.
New study shows how analyzing fluid from lungs can detect cancer mutations and guide personalized treatment decisions.
New liquid biopsy technique identifies molecular residual disease in colorectal cancer patients to guide personalized treatment decisions.
Innovative immunotherapy approach converts patient tumor cells into personalized vaccines to fight aggressive brain cancer.
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Liquid biopsy with next-generation sequencing shows promise for predicting glioma patient outcomes through circulating tumor DNA analysis.
New liquid biopsy technology identifies actionable cancer mutations in blood, enabling earlier detection and personalized treatment monitoring.